Fund search

LEGAL & GENERAL GLOBAL HEALTH & PHARMACEUTICAL INDEX R - Fund overview

No Bestinvest rating
Find rated global funds


Overview of LEGAL & GENERAL GLOBAL HEALTH & PHARMACEUTICAL INDEX R

The first trust to track global blue chip healthcare & pharmaceutical companies, it offers a passive option to technology investing with an emphasis on established giants. Our opinion however is that within emerging, specialist sectors, dedicated active managers add value and perform better.

Standard Initial Charge

0.00% 0.00%

Fund summary

Sector  Global
Product type  UNIT TRUST
Launched  November, 2000
Size  £175m
Yield 0.8%
Charging basis  Income
Dividends paid  7th March.
Bid price(inc) 36.54p
Bid price(acc) 40.23p

Fund Charges

Standard Initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.16%
Annual management charge 1.00%
Total expense ratio 1.00%
Reduction in yield (10yr) 1.02%

Bestinvest says


No information available.

Portfolio

legal & general global health & pharmaceutical index r asset allocation illustration
Allocation Proportion
Equity 100%
High yield bonds
Quality bonds
Property
Commodities
Hedge
Fund cash 0%
legal & general global health & pharmaceutical index r equity geographic illustration
Allocation Proportion
UK 10%
Europe 18%
Nth America 65%
Japan 5%
Pacific 1%
Other Equity 1%
legal & general global health & pharmaceutical index r equity capitalisation illustration
Allocation Proportion
Large Caps 88%
Mid Caps 12%
Small Caps 0%

Investment process


The investment objective is to secure capital growth from a portfolio of securities of companies engaged in Health and Pharmaceuticals. Securities representing all such companies in the developed and advanced emerging segments of the FTSE All-World Index will normally be held with weighting generally proportionate to their market capitalisation.
The largest 90% of companies by market cap are covered, which number around 90. Since Pfizer exceeds the 10% limit in any one stock imposed by IMRO, the trust will hold Medium Term Notes to simulate the performance of the shares. The fund fully replicates the index.

Version: unknown